共 143 条
[1]
Melton LJ(1997)Fractures attributable to osteoporosis; Report from the National Osteoporosis Foundation J Bone Miner Res 12 16-23
[2]
Thamer R(2001)Clinical practice guidelines for the prevention and treatment of postmenopausal osteoporosis Endocrine Practice 7 293-312
[3]
Ray NF(2001)Osteoporosis Prevention, Diagnosis, and Therapy JAMA 285 785-795
[4]
Chan JK(2002)Meta-analysis of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for post menopausal osteoporosis Endocr Rev 23 570-578
[5]
Chestnut CH(2004)Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis J Bone Min Res 19 1241-1249
[6]
Einhorn TA(2002)Long term persistence in use of statin therapy in elderly patients JAMA 288 455-461
[7]
Johnston CC(1997)Assessing compliance to antihypertensive medication using computer-based pharmacy records Med Car 35 1164-1170
[8]
Raisz LG(1997)Compliance with treatment regimens in chronic asymptomatic diseases Am J Med 102 43-49
[9]
Silverman SL(2003)Compliance with pharmacologic therapy for osteoporosis Osteoporos Int 14 965-968
[10]
Siris ES(2004)The impact of compliance with osteoporosis therapy on fracture rates in actual practice Osteoporos Int 15 1003-1008